LIGAND PHARM Backtesting

LGNZZ -- USA Stock  

USD 0.08  0.0025  3.23%

With this equity back-testing module your can estimate the performance of a buy and hold strategy of LIGAND PHARM INC and determine expected loss or profit from investing in LIGAND PHARM over given investment horizon. Please see also LIGAND PHARM Hype Analysis, LIGAND PHARM Correlation, LIGAND PHARM Valuation, LIGAND PHARM Volatility as well as analyze LIGAND PHARM Alpha and Beta and LIGAND PHARM Performance.
Horizon     30 Days    Login   to change
SymbolX
Backtest

LIGAND PHARM 'What if' Analysis

October 22, 2018
0.00
No Change 0.00  0.0%
In 31 days
November 21, 2018
0.00
If you would invest  0.00  in LIGAND PHARM on October 22, 2018 and sell it all today you would earn a total of 0.00 from holding LIGAND PHARM INC or generate 0.0% return on investment in LIGAND PHARM over 30 days. LIGAND PHARM is related to or competes with U S, Apple, Ecopetrol, Microsoft, Amazon, Vedanta, and Alphabet.

LIGAND PHARM Upside/Downside Indicators

Information Ratio0.0926
Maximum Drawdown31.76
Value At Risk5.56
Potential Upside3.33
  

LIGAND PHARM Market Premium Indicators

Risk Adjusted Performance0.1062
Jensen Alpha0.438
Total Risk Alpha0.7487
Treynor Ratio1.16

LIGAND PHARM INC Backtested Returns

Macroaxis considers LIGAND PHARM to be abnormally risky. LIGAND PHARM INC has Sharpe Ratio of -0.161 which conveys that LIGAND PHARM INC had -0.161% of return per unit of risk over the last 1 month. Macroaxis philosophy towards estimating risk of any stock is to look at both systematic and un-systematic factors of the business, including all available market data and technical indicators. LIGAND PHARM exposes twenty-six different technical indicators which can help you to evaluate volatility that cannot be diversified away. Please be advised to verify LIGAND PHARM INC Mean Deviation of 2.3 and Risk Adjusted Performance of 0.1062 to check out risk estimate we provide. Macroaxis gives LIGAND PHARM performance score of 0 on a scale of 0 to 100. The company secures Beta (Market Risk) of 0.3528 which conveys that as returns on market increase, LIGAND PHARM returns are expected to increase less than the market. However during bear market, the loss on holding LIGAND PHARM will be expected to be smaller as well.. Even though it is essential to pay attention to LIGAND PHARM INC price patterns, it is always good to be careful when utilizing equity historical price patterns. Macroaxis philosophy towards estimating future performance of any stock is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. LIGAND PHARM exposes twenty-six different technical indicators which can help you to evaluate its performance. LIGAND PHARM INC has expected return of -0.4679%. Please be advised to verify LIGAND PHARM INC Value At Risk, Kurtosis and the relationship between Sortino Ratio and Semi Variance to decide if LIGAND PHARM INC past performance will be repeated in the future.
Advice Volatility Trend Exposure Correlations
15 days auto-correlation 0.42 
correlation synergy

Average predictability

LIGAND PHARM INC has average predictability. Overlapping area represents the amount of predictability between LIGAND PHARM time series from October 22, 2018 to November 6, 2018 and November 6, 2018 to November 21, 2018. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of LIGAND PHARM INC price movement. The serial correlation of 0.42 indicates that just about 42.0% of current LIGAND PHARM price fluctuation can be explain by its past prices.
Correlation Coefficient0.42
Spearman Rank Test-0.34
Residual Average0.0
Price Variance0.0

LIGAND PHARM INC lagged returns against current returns

 Current and Lagged Values 
      Timeline 

LIGAND PHARM regressed lagged prices vs. current prices

 Current vs Lagged Prices 
      Timeline 

LIGAND PHARM Lagged Returns

 Regressed Prices 
      Timeline 

Current Sentiment - LGNZZ

LIGAND PHARM INC Investor Sentiment

Macroaxis portfolio users are evenly split in their trading attitude regarding investing in LIGAND PHARM INC. What is your trading attitude regarding investing in LIGAND PHARM INC? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see also LIGAND PHARM Hype Analysis, LIGAND PHARM Correlation, LIGAND PHARM Valuation, LIGAND PHARM Volatility as well as analyze LIGAND PHARM Alpha and Beta and LIGAND PHARM Performance. Please also try Fund Screener module to find activelly-traded funds from around the world traded on over 30 global exchanges.
Search macroaxis.com